Mei Wei, MD, an oncologist specializing in breast cancer at Huntsman Cancer Institute at the University of Utah, discusses advancements in breast cancer treatment, highlighting CDK4/6 inhibitors and ...

UCSB Arts & Lectures and the Cancer Foundation of Santa Barbara host the Nobel Prize–winning biochemist for a talk on CRISPR ...

Calm may have returned to Sebi after a turbulent period of employee protests and public controversies surrounding Madhabi Puri Buch’s leadership. But her future as Sebi chairperson remains ...

Capital market regulator Securities and Exchange Board of India (Sebi) has granted in-principle approval to Jio Financial Services and BlackRock Financial Management Inc to act as co-sponsors and set ...

Dr. Arian Mowlavi, a plastic surgeon who branded ... including those who sought treatment from Mowlavi in the summer of 2021. The criminal complaint states that Mowlavi “took advantage of ...

And it's simple. Half of all breast cancer cases are preventable, according to decades of research. In Dr. Kristi Funk's estimation, as many as 90% of cases are preventable. Dr. Funk, breast cancer ...

In a move aimed at safeguarding small investors and enhancing market stability, the Securities and Exchange Board of India (Sebi) has unveiled a series of new measures to strengthen the index ...

Renée Herman Garber says she had to learn to let others help her as she treats her metastatic breast cancer — and shares what has been most helpful throughout her treatment Wendy Grossman ...

To curb excessive speculation in the stock market, Sebi is tightening the rules for futures and options (F&O) trading. Starting November 20th, the minimum amount needed to invest in index F&O ...

The Securities and Exchange Board of India (SEBI) Tuesday tightened the norms for equity derivatives ... and removal of calendar spread treatment on the expiry day. These measures are expected to ...

A recent Sebi study found that 93 per cent of over 1 crore individual traders in the F&O segment lost an average of around Rs 2 lakh each (including transaction costs) between FY22 and FY24. | Image: ...

A reason being cited for this is the damage caused to the reputation of the equity markets regulator by the allegations made against her by Hindenburg Research.